FYERS
Home
/
Stocks
/
Profit Loss
/
Sudarshan Pharma Industries Profit & Loss

Sudarshan Pharma Industries Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
₹174 Cr₹221 Cr₹168 Cr₹169 Cr₹145 Cr₹162 Cr₹116 Cr₹129 Cr₹99 Cr
₹1 Cr₹4 Cr₹2 Cr₹2 Cr₹1 Cr₹84 L₹51 L₹32 L₹98 L
₹176 Cr₹225 Cr₹170 Cr₹171 Cr₹146 Cr₹162 Cr₹116 Cr₹129 Cr₹100 Cr
₹160 Cr₹202 Cr₹158 Cr₹161 Cr₹135 Cr₹146 Cr₹108 Cr₹116 Cr₹98 Cr
₹17 Cr₹24 Cr₹12 Cr₹11 Cr₹12 Cr₹17 Cr₹8 Cr₹13 Cr₹3 Cr
₹8 Cr₹8 Cr₹6 Cr₹6 Cr₹6 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr
₹8 Cr₹16 Cr₹5 Cr₹4 Cr₹5 Cr₹10 Cr₹4 Cr₹8 Cr-₹2 Cr
₹6 Cr₹11 Cr₹4 Cr₹4 Cr₹4 Cr₹7 Cr₹3 Cr₹6 Cr-₹1 Cr

Share Price Live Stats

Open (₹)39.00
Volume (₹)11.44 L
High (₹)40.95
Upper Circuit40.97
Low (₹)39.00
Lower Circuit37.07
Prev Close39.02
52W High (₹)42.79
Price40.39
52W Low (₹)18.50

Share Market Cap & Key Ratios Overview

M.Cap (₹)992.94 Cr
Div. Yield (%)0.00
PE Ratio39.52
Debt to Equity1.34
Price to Book5.76
Book Value5.30
EPS (TTM)0.99
Face Value1.00
ROE (%)13.33

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
SUDARSHAN-MNSE
LTP
1W Low
1W High
Market cap (₹)
1901.45-18.65 (-0.97%)
1900.10
1964.85
4,56,833Cr
9186.55-82.45 (-0.89%)
9051.85
9296
2,45,426Cr
4863.65-171.35 (-3.40%)
4863.65
5049
1,87,320Cr
1132.6-54.4 (-4.58%)
1126
1191.45
1,13,217Cr
1379.25-38.75 (-2.73%)
1377
1426.20
1,12,212Cr
1855-80.3 (-4.15%)
1812
1947.90
1,01,155Cr
2124.4-50.6 (-2.33%)
2117.80
2209
97,626Cr
2337.45-49.95 (-2.09%)
2323.15
2407.40
96,859Cr
1163.1-14.7 (-1.25%)
1155
1179.90
96,406Cr
1657.6+7.6 (0.46%)
1623.05
1706.70
93,614Cr
40.39+0.52 (1.30%)
37.86
40.95
993Cr

Key Highlights of Sudarshan Pharma Industries Ltd’s P&L

In 2025-03-31, Sudarshan Pharma Industries Ltd reported total revenue of ₹507.57Cr, compared with ₹466.15Cr in 2024-03-31, reflecting Sudarshan Pharma Industries Ltd turnover.

Depreciation was ₹2.22Cr and finance costs were ₹15.77Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹21.63Cr in 2025-03-31 as compared to ₹15.23Cr in 2024-03-31.

Net Profit (PAT) was ₹15.96Cr in 2025-03-31 compared with ₹11.46Cr in 2024-03-31.

Earnings per share (EPS) were ₹0.66 in 2025-03-31, compared with ₹4.76 in 2024-03-31.